New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
16:08 EDTMOHMolina Healthcare sees FY13 EPS $1.45, consensus $1.56
Sees FY13 revenue $7.0B, consensus $7.04B. Molina Healthcare updated its 2013 guidance provided on February 7 to include the impact of the issuance of $550M aggregate principal amount of cash convertible senior notes on February 15, and certain projected increases to its premium revenue. Updated 2013 guidance includes operating income expected to increase $10M, or 13c per diluted share, compared with previously issued guidance due to newly expected increases in premium revenue. The issuance of the $550M of cash convertible senior notes is expected to reduce earnings per diluted share by approximately 23c, the company said.
News For MOH From The Last 14 Days
Check below for free stories on MOH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2014
06:32 EDTMOHPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use